2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Tuesday, May 2, 2017

5:06pm-5:18pm: A Novel Belatacept Regimen to Optimize Efficacy and Safety.

D. Wojciechowski,¹ S. Chandran,² M. Sarwal,² J. Yang,² F. Vincenti.²

Concurrent Session: Novel Immunosuppression Regimens - Belatacept • E354b

5:06pm-5:18pm: At-Home Transplant Education Increases Black and Low-Income Dialysis Patients' Transplant Knowledge, Attitudes, Informed Decision-Making, and Pursuit: An Explore Transplant @ Home Randomized Controlled Trial.

A. Waterman,¹ J. Peipert,¹ A.-M. McSorley,¹ C. Goalby,¹ L. Peace.²

Concurrent Session: Disparities in Kidney Transplantation • E451a

5:06pm-5:18pm: Clinical Outcomes of ABO and HLA Incompatible Kidney Transplantation – Nationwide Cohort Study.

E. Ko,^1,2 J. Yu,^1,2 C. Yang,^1,2 B. Chung,^1,2 Korean Organ Transplantation Registry (KOTRY).

Concurrent Session: Long Term Kidney Graft Survival II • E450a

5:06pm-5:18pm: CTLA4Ig Suppresses Memory Responses to HLA-A2⁺ Skin Grafts in a Mouse Model of Allosensitization by Reducing CD138⁺ Plasma Cells.

G. Wu, I. Kim, N.-N. Chai, S. Jordan, A. Klein.

Concurrent Session: B Cells: Regulation and Tolerance • E350

5:06pm-5:18pm: Cultural Competency of a Mobile, Customized Patient Education Tool for Improving Potential Kidney Transplant Recipients' Knowledge and Decision-Making.

D. Axelrod,¹ C. Kynard-Amerson,² D. Wojciechowski,³ K. Lentine,⁴ M. Schnitzler,⁴ J. Peipert,² A. Waterman.²

Concurrent Session: Economics and Outcomes in Organ Transplantation • E271a

5:06pm-5:18pm: Efficacy and Safety of Everolimus with Reduced-Exposure Tacrolimus and Corticosteroid Withdrawal in De Novo Pediatric Renal Transplant Recipients: 12-Month Results from the CRADLE Study.

R. Ettenger,¹ B. Tönshoff,¹ H. Tedesco,¹ L. Dello Strologo,¹ S. Marks,¹ L. Pape,¹ E. Martzloff,² B. Rauer,² J. Ng,³ P. Lopez.²

Concurrent Session: Late Breaking • E353C

5:06pm-5:18pm: Genomic Diversity of Epstein-Barr Virus in Post-Transplant Lymphoproliferative Disorder.

E. Maloney, O. Martinez.

Concurrent Session: PTLD • E271b

5:06pm-5:18pm: Higher Mortality Among Candidates Who Refuse to Accept DCD Kidney Offers.

M. Bowring, A. Massie, D. Segev.

Concurrent Session: DCD and Infectious Risk Kidney Donors • E450b

5:06pm-5:18pm: Long-Term Drug-Free Survival of Tiny Cynomolgus Islet Allografts.

M. Koulmanda, V. Chipashivili, M. Duggan, T. Strom.

Concurrent Session: Islet Transplant • E352

5:06pm-5:18pm: No Gains in Long-Term Survival Following Liver Transplantation Over the Past Three Decades.

A. Rana,¹ M. Kueht,¹ J. Moffett,¹ N. Galvan,¹ R. Cotton,¹ J. Vierling,^1,2 A. Mindikoglu,^1,2 C. O'Mahony,¹ J. Goss.¹

Concurrent Session: Liver: Immunosuppression and Rejection • E451b